Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 4
2008 3
2009 2
2011 1
2012 2
2013 1
2014 4
2015 9
2016 7
2017 10
2018 7
2019 3
2020 6
2021 9
2022 24
2023 8
Text availability
Article attribute
Article type
Publication date

Search Results

91 results
Results by year
Filters applied: . Clear all
Page 1
Update of EULAR recommendations for the treatment of systemic sclerosis.
Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Clements P, Cutolo M, Czirjak L, Damjanov N, Del Galdo F, Denton CP, Distler JHW, Foeldvari I, Figelstone K, Frerix M, Furst DE, Guiducci S, Hunzelmann N, Khanna D, Matucci-Cerinic M, Herrick AL, van den Hoogen F, van Laar JM, Riemekasten G, Silver R, Smith V, Sulli A, Tarner I, Tyndall A, Welling J, Wigley F, Valentini G, Walker UA, Zulian F, Müller-Ladner U; EUSTAR Coauthors. Kowal-Bielecka O, et al. Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9. Ann Rheum Dis. 2017. PMID: 27941129 Free article.
Luchetti MM, Moroncini G, Svegliati S, Larcher F, Avvedimento EV, Gabrielli A. Luchetti MM, et al. Among authors: moroncini g. Arthritis Rheumatol. 2017 Aug;69(8):1703-1704. doi: 10.1002/art.40138. Epub 2017 Jun 14. Arthritis Rheumatol. 2017. PMID: 28464528 No abstract available.
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region.
Lescoat A, Huscher D, Schoof N, Airò P, de Vries-Bouwstra J, Riemekasten G, Hachulla E, Doria A, Rosato E, Hunzelmann N, Montecucco C, Gabrielli A, Hoffmann-Vold AM, Distler O, Ben Shimol J, Cutolo M, Allanore Y; EUSTAR collaborators. Lescoat A, et al. Rheumatology (Oxford). 2022 Oct 12:keac576. doi: 10.1093/rheumatology/keac576. Online ahead of print. Rheumatology (Oxford). 2022. PMID: 36222557
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways.
López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, Beretta L, Simeón CP, Carreira P, Ortego-Centeno N, Castellvi I, Bossini-Castillo L, Carmona FD, Orozco G, Hunzelmann N, Distler JHW, Franke A, Lunardi C, Moroncini G, Gabrielli A, de Vries-Bouwstra J, Wijmenga C, Koeleman BPC, Nordin A, Padyukov L, Hoffmann-Vold AM, Lie B; European Scleroderma Group†; Proudman S, Stevens W, Nikpour M; Australian Scleroderma Interest Group (ASIG); Vyse T, Herrick AL, Worthington J, Denton CP, Allanore Y, Brown MA, Radstake TRDJ, Fonseca C, Chang HY, Mayes MD, Martin J. López-Isac E, et al. Among authors: moroncini g. Nat Commun. 2019 Oct 31;10(1):4955. doi: 10.1038/s41467-019-12760-y. Nat Commun. 2019. PMID: 31672989 Free PMC article.
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.
Zanatta E, Huscher D, Ortolan A, Avouac J, Airò P, Balbir-Gurman A, Siegert E, Matucci Cerinic M, Cozzi F, Riemekasten G, Hoffmann-Vold AM, Distler O, Gabrielli A, Heitmann S, Hunzelmann N, Montecucco C, Morovic-Vergles J, Ribi C, Doria A, Allanore Y; EUSTAR collaborators. Zanatta E, et al. Rheumatology (Oxford). 2022 Nov 28;61(12):4786-4796. doi: 10.1093/rheumatology/keac188. Rheumatology (Oxford). 2022. PMID: 35348643
Agonistic antibodies in systemic sclerosis.
Moroncini G, Svegliati Baroni S, Gabrielli A. Moroncini G, et al. Immunol Lett. 2018 Mar;195:83-87. doi: 10.1016/j.imlet.2017.10.007. Epub 2017 Oct 13. Immunol Lett. 2018. PMID: 29032187 Review.
Putative functional pathogenic autoantibodies in systemic sclerosis.
Benfaremo D, Svegliati Baroni S, Manfredi L, Moroncini G, Gabrielli A. Benfaremo D, et al. Among authors: moroncini g. Eur J Rheumatol. 2020 Oct;7(Suppl 3):S181-S186. doi: 10.5152/eurjrheum.2020.19131. Epub 2020 Oct 1. Eur J Rheumatol. 2020. PMID: 33164733 Free PMC article. Review.
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis.
Paolini C, Agarbati S, Benfaremo D, Mozzicafreddo M, Svegliati S, Moroncini G. Paolini C, et al. Among authors: moroncini g. Int J Mol Sci. 2022 Mar 31;23(7):3904. doi: 10.3390/ijms23073904. Int J Mol Sci. 2022. PMID: 35409263 Free PMC article. Review.
Biologics in Inflammatory Immune-mediated Systemic Diseases.
Moroncini G, Calogera G, Benfaremo D, Gabrielli A. Moroncini G, et al. Curr Pharm Biotechnol. 2017;18(12):1008-1016. doi: 10.2174/1389201019666171226152448. Curr Pharm Biotechnol. 2017. PMID: 29278213 Review.
91 results